Events
Achieving precise extrahepatic delivery remains one of the biggest challenges in the LNP field. However, with AbbVie’s acquisition of Capstan Therapeutics and BMS’s acquisition of Orbital Therapeutics, the industry’s confidence in targeted LNPs has never been higher!
Returning to Boston in June 2026, the 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit is bringing together industry pioneers and leading delivery experts to showcase the latest advances in novel targeting ligands and innovative lipid-based technologies. Across 3 jam-packed days, attendees will gain in-depth technical insights into accelerating the delivery of mRNA, RNA, gene-editing, and cell therapy payloads to extrahepatic tissues, including immune cells, adipose tissues, muscle, and more.
With world-class speaker…
Establish Procurement Excellence for R and D Innovation, Drive Supplier Value and Accelerate Study Timelines Through AI and Strategic Initiatives.
R and D procurement is undergoing a major transformation as organizations shift from transactional buying to strategic, innovation-driven value creation across the development pipeline. Procurement teams are navigating unprecedented complexity: strengthening global sourcing models amid geopolitical instability, extracting true value from CRO and CMO partnerships, integrating AI and orchestration tools to streamline operations, and aligning internal stakeholders around business continuity, speed, and scientific ambition. At the same time, the demands of emerging modalities, digital trial technologies, and evolving supplier ecosystems require more…
Foster Innovation and Collaboration at the 10th Annual Pre-Filled Syringes and Injectable Drug Devices West Coast Conference!
Join us in June 2026 as SAE Media Group's renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery.
This year's conference will bring a brand NEW focus day followed by the two-day main conference offering an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators.
What You'll Gain:
Actionable insights to strengthen your drug-device portfolio.Opportunities to network with key players shaping the injectable drug delivery landscape.A future-focused perspective…
Bispecifics and T-cell engagers are redefining the future of solid tumor treatment. With the landmark approvals of tarlatamab and ivonescimab, the spotlight is firmly on these modalities as powerful solutions for long-standing unmet needs. At the same time, the field is rapidly evolving beyond first-generation designs, with innovations in co-stimulation, conditional activation, multispecific engineering, and affinity tuning aimed at deepening response rates while mitigating dose-limiting toxicities.
Innovation is rife within Korea, with companies such as ABL Bio, Novelty Nobility, ABION, and IM Biologics capturing international attention and investment, positioning Korea as a key player in the bispecific and TCE revolution.
To accelerate this momentum, the inaugural World Bispecific and T-…
In 2025, cell and gene therapy reached a pivotal moment. Amid rising tariffs, shifting regulations, and capacity constraints, the industry gained clarity on what it takes to scale successfully. As a result, the focus on scaling novel therapies safely and efficiently has never been stronger, introducing a new era of operational excellence and expanded patient access.
As we enter 2026, AI, digitalization, and IoT are transforming how cell and gene therapies are planned, tracked, and delivered end-to-end. With smarter, data-driven decision-making, supply chain teams can better navigate tariff fluctuations, manufacturing variability, and regulatory complexity.
Designed by and for supply chain leaders across biopharma, including Roche, Bristol Myers Squibb, Johnson and Johnson, Genentech, ProKi…
The 5th World ADC Summit South Korea (9-11 June 2026 | Seoul) is Asia's premier meeting dedicated to accelerating next-generation antibody drug conjugate (ADC) development. As part of the broader World Targeted Therapeutics Summit South Korea, it sits alongside the World TPD and Induced Proximity Summit South Korea and the World Bispecifics and T-Cell Engager Summit South Korea, creating a unified hub for cutting-edge targeted therapeutics innovation.
The event brings together more than 300 experts from Korean and global biopharma to address the country's rapid shift from biosimilars toward high-value, first- and best-in-class ADCs. With novel payloads, dual-payload platforms, bispecific ADCs, and strategies to overcome Topo-1 resistance at the forefront, the summit provides end-to-end ins…
NHS ConfedExpo 2026 is the UK’s leading health and care conference, dedicated to improving care for patients and the public.
Join over 6,800+ health and care professionals, leaders, and partners for two days of collaboration, insight, and innovation. This is your opportunity to influence the future of health and care, share good practice, and discover solutions that deliver high-quality care for all.
Be a part of the conversation shaping the future of health and care.
The T-cell engager field is advancing faster than ever. With multiple clinical approvals validating the staying power of this modality, and a new wave of next-generation solid tumor and autoimmune programs moving rapidly towards the clinic, the momentum behind T-Cell engagers has never been stronger. These therapies are increasingly cited as one of the most promising drivers of the next era of immunotherapy.
Over the past year, the sector has experienced a surge of investment, deal-making and strategic collaboration. Landmark partnerships such as BMS x JanuX Therapeutics, Candid Therapeutics x WuXi Biologics and AbbVie x EvolveImmune signal growing confidence in the transformative potential of immune-redirecting platforms and reinforce commitment to advancing TCE innovation across oncology…
The bispecific and multispecific antibody field is advancing rapidly, fuelled by strong clinical readouts, growing biopharma investment, and increasingly sophisticated antibody designs. As programs evolve beyond first-generation bispecifics toward trispecific and multispecific strategies, the industry is sharpening its focus on improving efficacy while expanding the therapeutic window through improved safety and toxicity profiles.
With an increasing number of bispecifics progressing toward the clinic, the inaugural World Bispecific Summit Europe brings Europe's bispecific leaders together for the first time, building on the proven success of the World Bispecific Summit US.
This industry-led forum delivers deep technical discussions and case studies spanning novel antibody formats, next-gen…
The bispecific and multispecific antibody field is advancing rapidly, fuelled by strong clinical readouts, growing biopharma investment, and increasingly sophisticated antibody designs. As programs evolve beyond first-generation bispecifics toward trispecific and multispecific strategies, the industry is sharpening its focus on improving efficacy while expanding the therapeutic window through improved safety and toxicity profiles.
With an increasing number of bispecifics progressing toward the clinic, the inaugural World Bispecific Summit Europe brings Europe's bispecific leaders together for the first time, building on the proven success of the World Bispecific Summit US.
This industry-led forum delivers deep technical discussions and case studies spanning novel antibody formats, next-gen…
Scholars Conferences is thrilled to invite you to its upcoming scientific gathering “2nd Edition World Congress on Future of Aging & Rejuvenation Science” (WCFA 2026) to be held during July 20-21, 2026 at Vienna, Austria.
The conference strives to provide a meaningful theme of “Redefining Aging: Science, Innovation, and Longevity”
The WCFA 2026 Conference aims to showcase the latest advancements in gerontology and geroscience aimed at improving health and longevity, discuss the societal implications of aging, and promote sustainable practices and policies that support aging populations in an environmentally and economically viable manner. Key themes include pioneering gerontology, integrative approaches to longevity, advancing sustainable aging, bridging research and practice, enhancin…
Maximizing the Potential of Radiopharmaceuticals through Novel Targets, Expanded Isotopes and Supply, and Enhanced Dosimetry to Drive Efficacious Therapies From Bench to Approval.
Radiopharmaceuticals are no longer an emerging promise, they are becoming a defining force in oncology. Once considered a niche modality, targeted radiopharmaceutical therapies are rapidly moving into the spotlight as one of the most promising approaches for precision cancer treatment. With major pharmaceutical companies investing heavily, pipelines expanding at pace, and clinical successes demonstrating the power of targeted radiation delivery, the field is transitioning from early validation to scale.
Momentum across the sector is undeniable. Breakthrough therapies continue to advance through the clinic, alpha-…
ADC innovation is accelerating beyond traditional cytotoxins into dual-payload constructs, high-DAR species, degrader-antibody conjugates, and next-generation modalities. However, this rapid evolution is placing unprecedented pressure on linker architecture and conjugation chemistry to control stability, reduce off-target toxicity, overcome tumor resistance, and maintain manufacturability.
To meet these challenges head on, the 4th ADC Linker and Conjugation Summit offers a highly technical, deeply curated environment built specifically for specialists working at the cutting edge of ADC chemistry. At this summit, you aren't lost in a crowd, you're surrounded by peers who share the same job titles, scientific focus, and day-to-day challenges. Every session is built for specialists, every con…
Don’t miss the chance to attend the Marcus Evans 14th Edition Medical Device Safety Monitoring and Reporting conference taking place in San Diego between August 11-12! This event will offer attendees current knowledge and practical lessons on advancing routine monitoring and surveillance practices, while exploring new and emerging technologies and workflows. Attendees will be able to discuss how they can implement improvements on post market surveillance, reporting and complaint handling whilst avoiding uncertainties and risks that come from new technologies and automation techniques including AI.
Attending This Premier marcus evans Conference Will Enable You to:
Determine and define the optimal standards for medical device post-market monitoring beyond the minimum regulatory standa…
Don’t miss the chance to attend the Marcus Evans 14th Edition Medical Device Safety Monitoring and Reporting conference taking place in San Diego between August 11-12! This event will offer attendees current knowledge and practical lessons on advancing routine monitoring and surveillance practices, while exploring new and emerging technologies and workflows. Attendees will be able to discuss how they can implement improvements on post market surveillance, reporting and complaint handling whilst avoiding uncertainties and risks that come from new technologies and automation techniques including AI.
Attending This Premier marcus evans Conference Will Enable You to:
Determine and define the optimal standards for medical device post-market monitoring beyond the minimum regulatory standa…
The Global Infectious Diseases and One Health Conference (GIOH 2026) in London, United Kingdom, Online from August 17–19, 2026, unites health professionals, scientists, and policymakers committed to strengthening preparedness against infectious threats. The One Health congress offers a global perspective on how collaborative efforts can prevent and mitigate disease outbreaks.
Core discussions will focus on pandemic intelligence, surveillance systems, climate-driven infections, biosecurity frameworks, and antibiotic stewardship. Renowned experts will share strategies that enhance early detection, containment, and cross-sector coordination.
Participants will gain access to interactive workshops, expert dialogues, and live demonstrations showcasing new technologies that transform infectious d…
The Global Public Health and Epidemiology Congress (G-PHEC 2026) will take place from August 17–19, 2026, in London, United Kingdom, with a hybrid format offering both in-person and online participation.
The GloNurse Summit 2026, officially known as the Global Nursing Congress and Healthcare Innovation Summit, will take place August 17–19, 2026, in London, UK, and online. The Nursing Conferences aims to redefine global healthcare through innovation, evidence-based nursing, and cross-disciplinary collaboration.
Attendees for Nursing Science Event will explore topics such as ecosystems, leadership in nursing practice, global health education, patient engagement digital health, and mental health care reform. The conference will feature international speakers, academic researchers, policy experts, and frontline practitioners sharing insights on modern healthcare challenges and opportunities.
The Nursing Congress hybrid setup allows both physical and virtual attendees to benefit from networking…
It is my distinct pleasure to welcome you to the Global Summit on Artificial Intelligence 2026 (GSAI 2026), hosted here in Singapore—one of the world’s leading hubs of innovation and technology.
Under the theme “Shaping the Future,” this summit provides a global platform for thought leaders, researchers, policymakers, and industry pioneers to exchange insights on the evolving landscape of artificial intelligence. Over the next two days, we will explore how AI continues to transform economies, enhance societal well-being, and redefine the boundaries of what is possible.
GSAI 2026 aims to foster meaningful dialogue on the responsible development and deployment of AI technologies—balancing innovation with ethics, progress with inclusivity, and advancement with accountability. Together, we hav…
EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.The 24th EuroQSAR Symposium, entitled "Synergizing AI and Multiscale Modeling for Drug Discovery", is organised on behalf of QCMS and is chaired by Jordi Mestres (University of Girona).
The symposium will focus on:
Computational Design of Covalent Drugs
Free Energy and Kinetics of Drug-target Binding
Omics Science in Drug Discovery
Artificial Intelligence and Statistical Learning in Drug Discovery
QSAR and Machine Learning for DM/PK
In silico/in vitro Models for Drug Safety
Virtual Screening Successful Stories
Next-generation Docking: Focus on Conformational Entrop…
